STAGE IIB PROSTATE CANCER
Clinical trials for STAGE IIB PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation approach aims to control prostate cancer with fewer side effects
Disease control OngoingThis study tests a type of radiation therapy called high-dose-rate brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to deliver a strong dose of radiation to the tumor while sparing nearby healthy tiss…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Promising prostate cancer combo under study
Disease control OngoingThis early-phase trial studies the safety and best way to give enzalutamide alongside radiation and hormone therapy for men with intermediate or high-risk prostate cancer. The goal is to see if this combination can better control the disease by blocking androgens that fuel cancer…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New radiation cocktail aims to zap prostate cancer faster
Disease control OngoingThis early-stage study tests a new way to give radiation for intermediate risk prostate cancer. It combines two precise radiation methods: a short internal treatment (brachytherapy) followed by three weeks of focused external beams (SBRT). The goal is to find the safest dose and …
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New radiation approach aims to zap recurrent prostate cancer with fewer side effects
Disease control OngoingThis early-stage study tests a high-precision radiation technique called stereotactic body radiation therapy (SBRT) in 26 men whose prostate cancer has returned after surgery. The main goal is to find the safest and most effective dose by monitoring side effects. The approach tar…
Matched conditions: STAGE IIB PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:00 UTC